Company Profile
Vedere Bio II
Company Overview
Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast majority of ocular gene therapies only limit the rate of inevitable vision loss, we aim to restore lost vision regardless of a patient’s underlying genetics or their stage of disease.
Thanks to a team of pioneering scientists, Vedere’s gene therapy platform is poised to make vision restoration a reality. We are the first to show functional vision restoration in multiple pre-clinical models and are leading the way to bring this life-changing technology to patients.